Literature DB >> 28255288

Orbital Decompression for Thyroid Eye Disease.

Tara L Braun1, Mohin A Bhadkamkar1, Kevin T Jubbal1, Adam C Weber1, Douglas P Marx1.   

Abstract

Although most cases of thyroid eye disease (TED) can be managed medically, some refractory or severe cases are treated surgically with orbital decompression. Due to a lack of randomized controlled trials comparing surgical techniques for orbital decompression, none have been deemed superior. Thus, each case of TED is managed based on patient characteristics and surgeon experience. Surgical considerations include the extent of bony wall removal, the surgical approach, the choice of incision, and the use of fat decompression. Outcomes vary based on surgical indications and techniques; hence, vision can improve or worsen after the surgery.

Entities:  

Keywords:  Graves' ophthalmopathy; orbital decompression; orbital fat decompression; thyroid eye disease

Year:  2017        PMID: 28255288      PMCID: PMC5330789          DOI: 10.1055/s-0037-1598192

Source DB:  PubMed          Journal:  Semin Plast Surg        ISSN: 1535-2188            Impact factor:   2.314


  29 in total

1.  Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial.

Authors:  I M M J Wakelkamp; L Baldeschi; P Saeed; M P Mourits; M F Prummel; W M Wiersinga
Journal:  Clin Endocrinol (Oxf)       Date:  2005-09       Impact factor: 3.478

2.  Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures.

Authors:  M P Mourits; H Bijl; M A Altea; L Baldeschi; K Boboridis; N Currò; A J Dickinson; A Eckstein; M Freidel; C Guastella; G J Kahaly; R Kalmann; G E Krassas; C M Lane; J Lareida; C Marcocci; M Marino; M Nardi; Ch Mohr; C Neoh; A Pinchera; J Orgiazzi; S Pitz; P Saeed; M Salvi; S Sellari-Franceschini; M Stahl; G von Arx; W M Wiersinga
Journal:  Br J Ophthalmol       Date:  2008-11-21       Impact factor: 4.638

3.  Treatment of severe thyroid eye disease: a survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS).

Authors:  Balaji Perumal; Dale R Meyer
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2015 Mar-Apr       Impact factor: 1.746

Review 4.  Thyroid-associated ophthalmopathy: pathogenesis and clinical management.

Authors:  P Perros; P Kendall-Taylor
Journal:  Baillieres Clin Endocrinol Metab       Date:  1995-01

5.  Effect of orbital decompression on diplopia in thyroid-related orbitopathy.

Authors:  Norman P Mainville; David R Jordan
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2014 Mar-Apr       Impact factor: 1.746

6.  Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.

Authors:  C Marcocci; L Bartalena; M L Tanda; L Manetti; E Dell'Unto; R Rocchi; G Barbesino; B Mazzi; M P Bartolomei; P Lepri; F Cartei; M Nardi; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

7.  Proptosis reduction by clinical vs radiological modalities and medial vs inferomedial approaches: comparison following endoscopic transnasal orbital decompression in patients with dysthyroid orbitopathy.

Authors:  Suman Thapa; Ashok K Gupta; Amod Gupta; Vivek Gupta; Pinaki Dutta; Ramandeep S Virk
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-04       Impact factor: 6.223

8.  Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall?

Authors:  Mehmet Unal; Fikret Leri; Onur Konuk; Berati Hasanreisoğlu
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2003-03       Impact factor: 1.746

9.  A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.

Authors:  Mark F Prummel; Caroline B Terwee; Martin N Gerding; Lelio Baldeschi; Maarten P Mourits; Leo Blank; Friedo W Dekker; Wilmar M Wiersinga
Journal:  J Clin Endocrinol Metab       Date:  2004-01       Impact factor: 5.958

Review 10.  Immune mechanisms in thyroid eye disease.

Authors:  Geniece M Lehmann; Steven E Feldon; Terry J Smith; Richard P Phipps
Journal:  Thyroid       Date:  2008-09       Impact factor: 6.568

View more
  5 in total

1.  Orbital decompression surgery for the treatment of Graves' ophthalmopathy: comparison of different techniques and long-term results.

Authors:  Mehmet Ozgur Cubuk; Onur Konuk; Mehmet Unal
Journal:  Int J Ophthalmol       Date:  2018-08-18       Impact factor: 1.779

2.  Novel Approaches for Immunosuppression in Graves' Hyperthyroidism and Associated Orbitopathy.

Authors:  Alan Chun Hong Lee; George J Kahaly
Journal:  Eur Thyroid J       Date:  2020-08-10

Review 3.  Multidisciplinary approach to orbital decompression. A review.

Authors:  Claudio Parrilla; Dario Antonio Mele; Silvia Gelli; Lorenzo Zelano; Francesco Bussu; Mario Rigante; Gustavo Savino; Emanuele Scarano
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

Review 4.  Fat-removal orbital decompression for thyroid associated orbitopathy: The right procedure for the right patient.

Authors:  Eman Al-Sharif; Adel H Alsuhaibani
Journal:  Saudi J Ophthalmol       Date:  2017-06-14

Review 5.  Strategies in Surgical Decompression for Thyroid Eye Disease.

Authors:  Anny M S Cheng; Yi-Hsuan Wei; Shu-Lang Liao
Journal:  Oxid Med Cell Longev       Date:  2020-09-09       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.